Global Impact Through Strategic Partnerships
At MediWound, we believe that impactful partnerships drive meaningful progress. We are always seeking collaborations that amplify our reach and enhance patient care worldwide
NexoBrid®
Our commercial burn care biologic is available in over 40 countries through collaborations with the world’s leading burn care companies.
EscharEx®
Now in advanced clinical trials, our chronic wound care therapy is supported by partnerships with the largest global leaders in advanced wound management.
Governmental
Public health agencies worldwide have partnered with us to leverage our technology in addressing high-priority, unmet medical needs.